𝗧𝗵𝗲 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗼𝗳 𝗜𝗺𝗺𝘂𝗻𝗼𝗮𝘀𝘀𝗮𝘆𝘀 𝗶𝗻 𝗟𝗮𝘁𝗶𝗻 𝗔𝗺𝗲𝗿𝗶𝗰𝗮: 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗚𝗿𝗼𝘄𝘁𝗵 𝗮𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻

According to the latest report published by the Next Move Strategy Consulting, the Latin
America Immunoassay Market size was valued at USD 2.44 billion in 2023, and is predicted
to reach USD 3.67 billion by 2030, with a CAGR of 5.2% from 2024 to 2030

The Future of Immunoassays in Latin America: Trends and Predictions

The future of immunoassays in Latin America is shaped by technological advancements, growing healthcare demands, and a focus on accessibility.

See the full article: https://www.nextmsc.com/blogs/latin-america-immunoassay-market-trends

𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗩𝗗 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆: 𝗞𝗲𝘆 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗮𝗻𝗱 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀

In-vitro diagnostics (IVD) refers to the process of performing medical tests on samples such as blood, urine, or tissues outside the body, typically in a laboratory setting. In-vitro diagnostic (IVD) industry is a vital component of the healthcare sector, which provides essential information for disease diagnosis, treatment, and monitoring. The industry encompasses a wide range of diagnostic technologies, including clinical chemistry, immunoassays, molecular diagnostics, and microbiology. IVD tests are used to diagnose a range of conditions, including infectious diseases, cancer, and genetic disorders.